No Detail Found!

Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.

Author(s)
Semra Kara Department of Neonatology, Ankara Training and Research Hospital, Ankara, Turkey
Hulya Ulu-Ozkan Department of Paediatrics, Ankara Training and Research Hospital, Ankara, Turkey
Yavuz Yilmaz Department of Paediatrics, Ankara Training and Research Hospital, Ankara, Turkey
Fatma Inci Arikan Department of Paediatric Surgery, Zekai Tahir Burak Training and Research Hospital, Turkey
Ugur Dilmen Department of Neonatology, Zekai Tahir Burak Training and Research Hospital, Turkey
Yildiz Dallar Bilge Department of Paediatric Surgery, Zekai Tahir Burak Training and Research Hospital, Turkey
Abstract
ABO iso-immunization is the most frequent haemolytic disease of the newborn. Treatment depends on the total serum bilirubin level, which may increase very rapidly in the first 48 hours of life in cases of haemolytic disease of the newborn. Phototherapy and, in severe cases, exchange transfusion are used to prevent hyperbilirubinaemic encephalopathy. Intravenous immunoglobulins (IVIG) are used to reduce exchange transfusion. Herein, we present a female newborn who was admitted to the NICU because of ABO immune haemolytic disease. After two courses of 1 g/kg of IVIG infusion, she developed necrotizing enterocolitis (NEC). Administration of IVIG to newborns with significant hyperbilirubinaemia due to ABO haemolytic disease should be cautiously administered and followed for complications.
Publication Details
Page(s) 598-600
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 23, Issue: 8, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

65

Views